Filing Details
- Accession Number:
- 0001562180-23-000484
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-18 17:18:36
- Reporting Period:
- 2023-01-11
- Accepted Time:
- 2023-01-18 17:18:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1860782 | 2Seventy Bio Inc. | TSVT | Pharmaceutical Preparations (2834) | 863658454 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1885058 | Nicola Heffron | 60 Binney Street Cambridge MA 02142 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-01-11 | 128 | $10.63 | 89,242 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.25 to $10.78, inclusive. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.